Sven D Koch

3PUBLICATIONS
25CO-AUTHORS
Innate immunityNanomedicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 18, 2024
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.

Brandon J Essink, Craig Shapiro, Marie Grace Dawn Isidro

|Feb 17, 2019
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.

Martin Sebastian, Andreas Schröder, Birgit Scheel

Pageof 1